Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30007092HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30001285HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30012289HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30007093HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30004635HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30007094HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30015466HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30013971HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30004636HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30007095HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TCGA Plot Options
Drug Information
GeneTOP2A
DrugBank IDDB06013
Drug NameAldoxorubicin
Target IDBE0000742
UniProt IDP11388
Regulation Typeinhibitor
PubMed IDs25312684
CitationsChawla SP, Chua VS, Hendifar AF, Quon DV, Soman N, Sankhala KK, Wieland DS, Levitt DJ: A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma. Cancer. 2015 Feb 15;121(4):570-9. doi: 10.1002/cncr.29081. Epub 2014 Oct 13.
GroupsInvestigational
Direct ClassificationAnthracyclines
SMILESCOC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(CO)=NNC(=O)CCCCCN4C(=O)C=CC4=O)C(O)=C3C(=O)C2=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL2107818